- Presentations
- 6
- Markets
- 1
Hysingla ER is a brand of Hydrocodone marketed by Knoa Pharma, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Hydrocodone
- Brand owner
- Knoa Pharma
- Registered in
- United States
- Strengths and forms
- 100 mg extended-release tablet, 20 mg extended-release tablet, 30 mg extended-release tablet, 40 mg extended-release tablet, 60 mg extended-release tablet, 80 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Hysingla ER 100 mg extended-release tabletOral | Knoa Pharma | US FDA | Available on request |
| Hysingla ER 20 mg extended-release tabletOral | Knoa Pharma | US FDA | Available on request |
| Hysingla ER 30 mg extended-release tabletOral | Knoa Pharma | US FDA | Available on request |
| Hysingla ER 40 mg extended-release tabletOral | Knoa Pharma | US FDA | Available on request |
| Hysingla ER 60 mg extended-release tabletOral | Knoa Pharma | US FDA | Available on request |
| Hysingla ER 80 mg extended-release tabletOral | Knoa Pharma | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Hysingla ER
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.